node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
C6orf226 | EFCAB5 | ENSP00000386146 | ENSP00000378312 | Uncharacterized protein C6orf226; Chromosome 6 open reading frame 226. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.447 |
C6orf226 | NPHP3-ACAD11 | ENSP00000386146 | ENSP00000488520 | Uncharacterized protein C6orf226; Chromosome 6 open reading frame 226. | NPHP3-ACAD11 readthrough. | 0.662 |
CCDC105 | EFCAB5 | ENSP00000292574 | ENSP00000378312 | Coiled-coil domain containing 105. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.438 |
CCDC116 | EFCAB5 | ENSP00000292779 | ENSP00000378312 | Coiled-coil domain containing 116. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.511 |
CCDC116 | TCF23 | ENSP00000292779 | ENSP00000296096 | Coiled-coil domain containing 116. | Transcription factor 23; Inhibits E-box-mediated binding and transactivation of bHLH factors. Inhibitory effect is similar to that of ID proteins. Inhibits the formation of TCF3 and MYOD1 homodimers and heterodimers. Lacks DNA binding activity. Seems to play a role in the inhibition of myogenesis (By similarity). | 0.420 |
EFCAB5 | C6orf226 | ENSP00000378312 | ENSP00000386146 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Uncharacterized protein C6orf226; Chromosome 6 open reading frame 226. | 0.447 |
EFCAB5 | CCDC105 | ENSP00000378312 | ENSP00000292574 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Coiled-coil domain containing 105. | 0.438 |
EFCAB5 | CCDC116 | ENSP00000378312 | ENSP00000292779 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Coiled-coil domain containing 116. | 0.511 |
EFCAB5 | ERICH6 | ENSP00000378312 | ENSP00000295910 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Glutamate-rich protein 6; Glutamate rich 6. | 0.449 |
EFCAB5 | NPHP3-ACAD11 | ENSP00000378312 | ENSP00000488520 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | NPHP3-ACAD11 readthrough. | 0.546 |
EFCAB5 | NSRP1 | ENSP00000378312 | ENSP00000247026 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Nuclear speckle splicing regulatory protein 1; RNA-binding protein that mediates pre-mRNA alternative splicing regulation. | 0.725 |
EFCAB5 | OPRM1 | ENSP00000378312 | ENSP00000394624 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Mu-type opioid receptor; Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell typ [...] | 0.426 |
EFCAB5 | TCF23 | ENSP00000378312 | ENSP00000296096 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Transcription factor 23; Inhibits E-box-mediated binding and transactivation of bHLH factors. Inhibitory effect is similar to that of ID proteins. Inhibits the formation of TCF3 and MYOD1 homodimers and heterodimers. Lacks DNA binding activity. Seems to play a role in the inhibition of myogenesis (By similarity). | 0.423 |
EFCAB5 | TOR2A | ENSP00000378312 | ENSP00000362381 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | Torsin-2A; Torsin family 2 member A; Belongs to the ClpA/ClpB family. Torsin subfamily. | 0.456 |
EFCAB5 | WDR90 | ENSP00000378312 | ENSP00000293879 | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | WD repeat-containing protein 90; Required for efficient primary cilium formation. | 0.438 |
ERICH6 | EFCAB5 | ENSP00000295910 | ENSP00000378312 | Glutamate-rich protein 6; Glutamate rich 6. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.449 |
NPHP3-ACAD11 | C6orf226 | ENSP00000488520 | ENSP00000386146 | NPHP3-ACAD11 readthrough. | Uncharacterized protein C6orf226; Chromosome 6 open reading frame 226. | 0.662 |
NPHP3-ACAD11 | EFCAB5 | ENSP00000488520 | ENSP00000378312 | NPHP3-ACAD11 readthrough. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.546 |
NSRP1 | EFCAB5 | ENSP00000247026 | ENSP00000378312 | Nuclear speckle splicing regulatory protein 1; RNA-binding protein that mediates pre-mRNA alternative splicing regulation. | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.725 |
OPRM1 | EFCAB5 | ENSP00000394624 | ENSP00000378312 | Mu-type opioid receptor; Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell typ [...] | EF-hand calcium-binding domain-containing protein 5; EF-hand calcium binding domain 5. | 0.426 |